Chronic progesterone antagonist-estradiol therapy suppresses breakthrough bleeding and endometrial proliferation in a menopausal macaque model

Human Reproduction

Volumn 21, Issue 12, 2006, Pages 3081-3090

  Slayden, O D ^a   Zelinski, M B ^a   Chwalisz, K ^b   Hess Stumpp, H ^c   Brenner, R M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b TAP PHARMACEUTICAL PRODUCTS INC   (United States)

^c BAYER PHARMA AG   (Germany)

Author keywords

Endometrium; Estradiol; Hormone therapy; Progestin antagonist; Rhesus macaque

Indexed keywords

11BETA (4 ACETYLPHENYL) 17BETA HYDROXY 17ALPHA (1,1,2,2,2 PENTAFLUOROETHYL)ESTRA 4,9 DIEN 3 ONE; ANTIGESTAGEN; ESTRADIOL; ESTROGEN; GESTAGEN; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAKTHROUGH BLEEDING; CONTROLLED STUDY; DECIDUALIZATION; DRUG MECHANISM; ENDOMETRIUM; ENDOMETRIUM ATROPHY; ESTROGEN ACTIVITY; FEMALE; HORMONE SUBSTITUTION; LONG TERM CARE; MACACA; MAMMARY GLAND; MENOPAUSE; NONHUMAN; OVARIECTOMY; OVIDUCT; PRESCRIPTION; RHESUS MONKEY; TREATMENT DURATION; UTERINE CERVIX; VAGINA;

MACACA; MACACA MULATTA;

EID: 33751359445     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del282     Document Type: Article

References (52)

1. Anderson FD (1992) Bleeding and contraceptive steroids. In Alexander NJ and d'Argangues C (eds) Steroid Hormones and Uterine Bleeding. AAAS Press, Washington, DC, pp. 7-23.
2. Baird DT (2000) Clinical uses of antiprogestogens. J Soc Gynecol Invest 7,S49-S52.
3. Baird DT, Brown A, Critchley HO, Williams AR, Lin S and Cheng L (2003) Effect of long-term treatment with low-dose mifepristone on the endometrium. Hum Reprod 18,61-68.
4. Baskin GB, Smith SM and Marx PA (2002) Endometrial hyperplasia, polyps, and adenomyosis associated with unopposed estrogen in rhesus monkeys (Macaca mulatta) Vet Pathol 39,572-575.
5. Bennink C and Herjan JT (2004) Are all estrogens the same? Proc 3rd Eur Consensus Dev Conf Sex Steroids Cardiovasc Dis, 47,269-175.
6. Boerrigter PJ, van de Weijer PHM, Baak JPA, Fox H, Haspels AA and Kenemans P (1996) Endometrial response in estrogen replacement therapy quarterly combined with a progestogen. Maturitas 24,63-71.
7. Brenner RM and Slayden OD (1994) Cyclic changes in the primate oviduct and endometrium. In Knobil E and Neill JD (eds) The Physiology of Reproduction. Raven Press, New York, pp. 541-569.
8. Brenner RM, Slayden OD, Nayak NR, Baird DT and Critchley HO (2003) A role for the androgen receptor in the endometrial antiproliferative effects of progesterone antagonists. Steroids 68,1033-1039.
9. Burton KA, Henderson TA, Hillier SG, Mason JI, Habib F, Brenner RM and Critchley HO (2003) Local levonorgestrel regulation of androgen receptor and 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrium. Hum Reprod 18,2610-2617.
10. Bygdeman M, Gemzell Danielsson K, Marions L and Swahn M-L (1999) Contraceptive use of antiprogetsin. Eur. J Contracept Reprod Health Care 4,103-107.
11. Cameron ST, Critchley HOD, Thong KJ, Buckley CH, Williams AR and Baird DT (1996) Effects of daily low dose mifepristone on endometrial maturation and proliferation. Hum Reprod 11,2518-2526.
12. Cameron ST, Glasier AF, Narvekar N, Gebbie A, Critchley HO and Baird DT (2003) Effects of onapristone on postmenopausal endometrium. Steroids 68,1053-1059.
13. Carroll RS, Glowacka D, Dashner K and Black PM (1993) Progesterone receptor expression in meningiomas. Cancer Res 53,1312-1316.
14. Critchley H (2003) Endometrial effects of progestogens. Gynaecol Forum 8,6-10.
15. Curtis KM, Chrisman CE and Peterson HB (2002) Contraception for women in selected circumstances. Obstet Gynecol 99,1100-1112.
16. Eisinger SH, Meldrum S, Fiscella K, le Roux HD and Guzick DS (2003) Low-dose mifepristone for uterine leiomyomata. Obstet Gynecol 101,243-250.
17. Ettinger B (1998) Overview of estrogen replacement therapy: A historical perspective. Proc Soc Exp Biol Med 217,2-5.
18. Ettinger B, Selby JV, Citron JT, Ettinger VM and Zhang D (1993) Gynecologic complications of cyclic estrogen progestin therapy. Maturitas 17,197-204.
19. Fuhrmann U, Hess-Stumpp H, Cleve A, Neef G, Schwede W, Hoffmann J, Fritzemeier KH and Chwalisz K (2000) Synthesis and biological activity of a novel, highly potent progesterone receptor antagonist. J Med Chem 43,5010-5016.
20. Gemzell-Danielsson K, van Heusden AM, Killick SR, Croxatto HB, Bouchard P, Cameron S and Bygdeman M (2002) Improving cycle control in progestogen-only contraceptive pill users by intermittent treatment with a new anti-progestogen. Hum Reprod 17,2588-2593.
21. Glasier AF, Wang H, Davie JE, Kelly RW and Critchley HOD (2002) Administration of an anti-progesterone upregulates estrogen receptor in the endometrium of women using Norplant: A pilot study. Fertil Steril 77,366-372.
22. Grow DR, Williams RF, Hsiu JG and Hodgen GD (1996) Antiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance: A 1-year primate study. J Clin Endocrinol Metab 81,1933-1939.
23. Harman SM, Brinton EA, Clarkson T, Heward CB, Hecht HS, Karas RH, Judelson DR and Naftolin F (2004) Is the WHI relevant to HRT started in the perimenopause? Endocrine 24,195-202.
24. Hickey M and Fraser IS (2000) The structure of endometrial microvessels. Hum Reprod 15(Suppl 3),57-66.
25. Hirst JJ, Slayden OD, West NB and Brenner RM (1992) Androgens suppress estrogen and progestin receptors in the endometrium and oviduct of rhesus monkeys. In The Society for Gynecological Investigation Program and Abstracts: 39th Annual Meeting (held at San Antonio, TX, 18-21 March 1992), p. 309 (abstract 401).
26. Hisaw FL and Hisaw FL Jr (1961) Action of estrogen and progesterone on the reproductive tract of lower primates. In Young WC (ed.) Sex and Internal Secretions. Williams & Wilkins, Baltimore, pp. 556-589.
27. Kettel LM, Murphy AA and Morales AJ (1996) Treatment of endometriosis with the antiprogesterone mifepristone (RU486). Fertil Steril 65,23-28.
28. Lamberts SWJ, Tanghe HLJ, Avezaat CJJ, Braakman R, Wijngaarde R, Koper JW and de Jong FH (1992) Mifepristone (RU 486) treatment of meningiomas. J Neurol Neurosurg Psychiatry 55,486-490.
29. Marbaix E, Vekemans M, Galant C, Rigot V, Lemoine P, Dubois D, Picquet C, Henriet P, Twagirayezu P, Sufi S et al (2000) Circulating sex hormones and endometrial stromelysin-1 (matrix metalloproteinase-3) at the start of bleeding episodes in levonorgestrel-implant users. Human Reprod 2000 15,120-134.
30. Massai MR, Pavez M, Fuentealba B, Croxatto HB and d'Arcangues C (2004) Effect of intermittent treatment with mifepristone on bleeding patterns in Norplant (R) implant users. Contraception 70,47-54.
31. Moyer DL, de Lignieres B, Driguez P and Pez JP (1993) Prevention of endometrial hyperplasia by progesterone during long-term estradiol replacement: Influence of bleeding pattern and secretory changes. Fertil Steril 59,992-997.
32. Neulen J, Williams RF, Breckwoldt M, Chwalisz K, Baulieu EE and Hodgen GD (1996) Non-competitive anti-estrogenic actions of progesterone antagonists in primate endometrium: Enhancement of estrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms. Hum Reprod 11,1533-1537.
33. Newfield R, Spitz I, Isacson C and New M (2001) Long-term mifepristone (RU486) therapy resulting in massive benign endometrial hyperplasia. Clin Endocrinol (Oxf) 54,399-404.
34. Otto LN, Slayden OD, Clark AL and Brenner RM (2002) The rhesus macaque as an animal model for pelvic organ prolapse. Am J Obstet Gynecol 186,416-421.
35. Petersen RG (1985) Design and Analysis of Experiments, 66th edn. Marcel Dekker Inc., New York.
36. Pickar JH, Yeh I, Wheeler JE, Cunnane MF and Speroff L (2001) Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril 76,25-31.
37. Slayden OD and Brenner RM (1994) RU 486 action after estrogen priming in the endometrium and oviducts of rhesus monkeys (Macaca mulatta) J Clin Endocrinol Metab 78,440-448.
38. Slayden OD and Brenner RM (2003) Flutamide counteracts the antiproliferative effects of antiprogestins in the primate endometrium. J Clin Endocrinol Metab 88,946-949.
39. Slayden OD and Brenner RM (2004) Hormonal regulation and localization of estrogen, progestin and androgen receptors in the endometrium of nonhuman primates: Effects of progesterone receptor antagonists. Arch Histol Cytol 67,393-409.
40. Slayden OD, Hirst JJ and Brenner RM (1993) Estrogen action in the reproductive tract of rhesus monkeys during antiprogestin treatment. Endocrinology 132,1845-1856.
41. Slayden OD, Koji T and Brenner RM (1995) Microwave stabilization enhances immunocytochemical detection of estrogen receptor in frozen sections of macaque oviduct. Endocrinology 136,4012-4021.
42. Slayden OD, Zelinski-Wooten MB, Chwalisz K, Stouffer RL and Brenner RM (1998) Chronic treatment of cycling rhesus monkeys with low doses of the antiprogestin ZK 137, 316: Morphometric assessment of the uterus and oviduct. Hum Reprod 13,269-277.
43. Slayden OD, Nayak NR, Chwalisz K and Brenner RM (2000) Antiprogestin treatment increases androgen receptor in the macaque reproductive tract. Biol Reprod 62(Suppl 1), 70-71.
44. Slayden OD, Chwalisz K and Brenner RM (2001a) Reversible suppression of menstruation with progesterone antagonists in rhesus macaques. Hum Reprod 16,1562-1574.
45. Slayden OD, Nayak NR, Burton KA, Chwalisz K, Cameron ST, Critchley HO, Baird DT and Brenner RM (2001b) Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium. J Clin Endocrinol Metab 86,2668-2679.
46. Speroff L (2002) The impact of the Women's Health Initiative on clinical practice. J Soc Gynecol Invest 9,251.
47. Spitz IM and Robbins A (1998) Mechanism of action and clinical effects of antiprogestins on the non-pregnant uterus. Hum Reprod Update 4,584-593.
48. Stopinska-Gluszak U, Waligora J, Grzela T, Gluszak M, Jozwiak J, Radomski D, Roszkowski PI and Malejczyk J (2006) Effect of estrogen/ progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal women. J Reprod Immunol 69,65-75.
49. Suri NK (1997) Steroid content in endometrial tissue. East Afr Med J 74,242-248.
50. Tuckerman EM, Okon MA, Li T and Laird SM (2000) Do androgens have a direct effect on endometrial function? An in vitro study. Fertil Steril 74,771-779.
51. Wolf JP, Hsiu JG, Anderson TL, Ulmann A, Baulieu EE and Hodgen GD (1989) Noncompetitive antiestrogenic effect of RU 486 in blocking the estrogen-stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrate monkeys. Fertil Steril 52,1055-1060.
52. Zelinski-Wooten MB, Chwalisz K, Iliff SA, Niemeyer CL, Eaton GG, Loriaux DL, Slayden OD, Brenner RM and Stouffer RL (1998) A chronic, low dose regimen of the antiprogestin ZK 137 316 prevents pregnancy in rhesus monkeys. Hum Reprod 13,2132-2138.